Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggrenox
anorexia
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
anticonvulsants, blood level determination of
anticonvulsants, mechanism of action of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
apixaban
aspirin
aspirin, dose of
aspirin, failure of
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, thrombolytic agents in treatment
complications
controversies in neurology
dabigatran
dilantin, factors influencing metabolism of
dipyridamole
drowsiness
electroencephalogram
enzyme, serum
factor Xa inhibitor
fatigue
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic therapy, selection criteria
hepatic failure
hepatitis
idarucizumab
intracerebral hemorrhage
intracranial hemorrhage
liver disease
liver function enzymes
microhemorrhage, intracerebral
MRI
MRI, abnormal
MRI, gradient-echo
nausea and vomiting
neutropenia
non-vitamin K antagonist oral anticoagulants
PFA-100
platelet function test
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, selection
review article
risk factors
rivaroxaban
safety
seizure
seizure, tonic-clonic
seizure, treatment of
serum glutamic oxaloacetic transaminase
sodium valproate
sodium valproate, toxicity
thrombocytopenia
ticagrelor
tissue plasminogen activator, intravenous
topiramate
treatment of neurologic disorder
tremor
vasculopathy
weight gain
weight loss
Showing articles 750 to 800 of 6866 << Previous Next >>

Epilepsy in Elderly People
Lancet 355:1441-1446, Stephen,L.J.&Brodie,M.J., 2000

Managing Status Epilepticus
BMJ 320:953-954, Heafield,M.T.E., 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000

Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000

Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000

Special Report: Complications of Lumbar Puncture and Their Prevention with Atraumatic Lumbar Puncture Needles
Medscape:e7-e11, Evans,R.W., 2000

Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999

Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999

Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999

When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999

Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

Brief Antiepileptic Drug Withdrawal Prolongs Interval To Next Seizure
Neurol 53:1736-1741, Laowattana,S.,et al, 1999

Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999

A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation, A Randomized Controlled Trial
JAMA 282:737-743,779, Man-Son-Hing,M.,et al, 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999

Seizure Frequency and the Health-Related Quality of Life of Adults with epilepsy
Neurol 53:162-166, Leidy,N.K.,et al, 1999

Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999

Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999

Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999

Getting Oriented to Patient-Oriented Outcomes
Neurol 53:662-663, Vickrey,B.G., 1999

Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999

Reassessment:Vagus Nerve Stimulation for Epilepsy
Neurol 53:666-669, Fisher,R.S.&Handforth,A., 1999

Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999

When Should Heparin be Given to Patients with Atrial Fibrillation-Related Embolic Brain Infarcts?
Arch Neurol 56:1059-1060, Caplan,L.R., 1999

Heparin in Acute Stroke with Atrial Fibrillation, Clinical Relevance of Very Early Treatment
Arch Neurol 56:1098-1102,1059, Chamorro,A.,et al, 1999

Is There Still a Role for Intravenous Heparin in Acute Stroke? Yes
Arch Neurol 56:1159-1160,1162, Grau,A.J.&Hacke,W., 1999

Is There Still a Role for Intravenous Heparin in Acute Stroke? No
Arch Neurol 56:1160-1162, Sandercock,P., 1999

Major Bleeding During Anticoagulation after Cerebral Ischemia, Patterns and Risk Factors
Neurol 53:1319-1327, Gorter,J.W., 1999

Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999

Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999

Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999

A Double-Blind, Randomized Trial of Topiramate as Adjunctive Therapy for Partial-Onset Seizures in Children
Neurol 52:1338-1344, Elterman,R.D.,et al, 1999

Vagal Nerve Stimulation in epileptic Encephalopathies
Pediatrics 103:778-782, 821, Parker,A.P.J.,et al, 1999

Intravenous Heparin for Acute Stroke, What Can We Learn from the Megatrials?
Neurol 52:1746-1750, Swanson,R.A., 1999

Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999

Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999

ACTH Versus Vigabatrin Therapy in Infantile Spasms:A Retrospective Study
Neurol 52:1691-1694,1537, Cossette,P.,et al, 1999

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Vagus Nerve Stimulation for Medication-Resistant Generalized Epilepsy
Neurol 52:1510-1512, Labar,D.,et al, 1999

Left Vagal nerve Stimulation in Children with Medically Refractory epilepsy
J Pediatr 134:563-566, 532, Murphy,J.V.&Pediatric VNS Study Group, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999

A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
Arch Int Med 159:1248-1253, Johnson,E.S.,et al, 1999



Showing articles 750 to 800 of 6866 << Previous Next >>